Originally developed for diabetes, GLP-1 agonists like semaglutide (Ozempic/Wegovy) and liraglutide have become popular GLP-1s for weight management because they help patients significantly reduce body weight by curbing appetite and calorie intake
The ARC houses several neural populations that are critical for regulating appetite and energy balance, including hunger-promoting agouti-related peptideexpressing (AgRP-expressing) neurons (6569), satiety-inducing proopiomelanocortin-expressing (POMC-expressing) neurons (70, 71), and multiple other populations of appetite- and metabolism-regulating neurons (7275)
Losing even 5-10% of body weight can lead to dramatic improvements in overall health
Adcy 3, Mm00460371_ m1
Published on November 30th, 2025
Over the last 30 years, a number of aberrant biomarkers have been observed in the brain and other biological fluids of children with ASD, corroborating the hypothesis of a bio-energetic deficit in ASD children [14, 68]